(CCI) Crown Castle - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US22822V1017
Cell Towers, Fiber, Small Cells
Dividends
| Dividend Yield | 7.08% |
| Yield on Cost 5y | 4.89% |
| Yield CAGR 5y | 6.15% |
| Payout Consistency | 99.6% |
| Payout Ratio | 222.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.2% |
| Value at Risk 5%th | 38.2% |
| Relative Tail Risk | -4.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.39 |
| Alpha | -15.61 |
| CAGR/Max DD | -0.22 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.366 |
| Beta | 0.137 |
| Beta Downside | 0.181 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.29% |
| Mean DD | 24.26% |
| Median DD | 24.98% |
Description: CCI Crown Castle December 03, 2025
Crown Castle International (NYSE: CCI) owns and operates roughly 40,000 cell towers and about 90,000 route-miles of fiber that enable small-cell and fiber solutions across all major U.S. markets, forming a nationwide backbone that delivers wireless and data services to businesses and consumers.
Key metrics that shape its outlook include a 2023 revenue of approximately $8.6 billion, a funds-from-operations (FFO) yield near 5.5 %, and a leverage ratio of roughly 7.5× EBITDA-both of which are closely watched by REIT investors. The primary growth drivers are the continued rollout of 5G networks, which fuels demand for tower space and edge-computing fiber, and the secular increase in mobile data consumption that underpins long-term lease revenue stability.
For a deeper, data-driven assessment of CCI’s valuation and risk profile, you may find the ValueRay analytics platform useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-4.62b TTM) > 0 and > 6% of Revenue (6% = 290.5m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 4.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -65.74% (prev -17.54%; Δ -48.20pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 3.06b > Net Income -4.62b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.26 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (437.0m) change vs 12m ago 0.23% (target <= -2.0% for YES) |
| Gross Margin 73.36% (prev 73.70%; Δ -0.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 13.92% (prev 14.58%; Δ -0.66pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -3.17 (EBITDA TTM -2.03b / Interest Expense TTM 942.0m) >= 6 (WARN >= 3) |
Altman Z'' -3.94
| (A) -0.10 = (Total Current Assets 1.11b - Total Current Liabilities 4.30b) / Total Assets 31.50b |
| (B) -0.63 = Retained Earnings (Balance) -19.99b / Total Assets 31.50b |
| (C) -0.09 = EBIT TTM -2.98b / Avg Total Assets 34.77b |
| (D) -0.61 = Book Value of Equity -19.99b / Total Liabilities 32.99b |
| Total Rating: -3.94 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 34.81
| 1. Piotroski 3.0pt |
| 2. FCF Yield 3.87% |
| 3. FCF Margin 55.04% |
| 4. Debt/Equity -19.99 |
| 5. Debt/Ebitda -14.62 |
| 6. ROIC - WACC (= -16.72)% |
| 7. RoE 433.5% |
| 8. Rev. Trend -72.63% |
| 9. EPS Trend -43.52% |
What is the price of CCI shares?
As of December 06, 2025, the stock is trading at USD 89.28 with a total of 2,173,077 shares traded.
Over the past week, the price has changed by -2.19%, over one month by -0.61%, over three months by -6.10% and over the past year by -8.75%.
Over the past week, the price has changed by -2.19%, over one month by -0.61%, over three months by -6.10% and over the past year by -8.75%.
Is CCI a buy, sell or hold?
Crown Castle has received a consensus analysts rating of 3.71.
Therefor, it is recommend to hold CCI.
- Strong Buy: 6
- Buy: 3
- Hold: 12
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 115.1 | 28.9% |
| Analysts Target Price | 115.1 | 28.9% |
| ValueRay Target Price | 90.5 | 1.4% |
CCI Fundamental Data Overview November 24, 2025
Market Cap USD = 39.20b (39.20b USD * 1.0 USD.USD)
P/E Forward = 25.3165
P/S = 6.1055
P/B = 8.8551
P/EG = 1.3384
Beta = 0.961
Revenue TTM = 4.84b USD
EBIT TTM = -2.98b USD
EBITDA TTM = -2.03b USD
Long Term Debt = 21.55b USD (from longTermDebt, last quarter)
Short Term Debt = 3.31b USD (from shortTermDebt, last quarter)
Debt = 29.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.61b USD (from netDebt column, last quarter)
Enterprise Value = 68.81b USD (39.20b + Debt 29.84b - CCE 233.0m)
Interest Coverage Ratio = -3.17 (Ebit TTM -2.98b / Interest Expense TTM 942.0m)
FCF Yield = 3.87% (FCF TTM 2.67b / Enterprise Value 68.81b)
FCF Margin = 55.04% (FCF TTM 2.67b / Revenue TTM 4.84b)
Net Margin = -95.37% (Net Income TTM -4.62b / Revenue TTM 4.84b)
Gross Margin = 73.36% ((Revenue TTM 4.84b - Cost of Revenue TTM 1.29b) / Revenue TTM)
Gross Margin QoQ = 73.88% (prev 73.77%)
Tobins Q-Ratio = 2.18 (Enterprise Value 68.81b / Total Assets 31.50b)
Interest Expense / Debt = 0.83% (Interest Expense 247.0m / Debt 29.84b)
Taxrate = 1.42% (4.00m / 281.0m)
NOPAT = -2.94b (EBIT -2.98b * (1 - 1.42%)) [loss with tax shield]
Current Ratio = 0.26 (Total Current Assets 1.11b / Total Current Liabilities 4.30b)
Debt / Equity = -19.99 (negative equity) (Debt 29.84b / totalStockholderEquity, last quarter -1.49b)
Debt / EBITDA = -14.62 (negative EBITDA) (Net Debt 29.61b / EBITDA -2.03b)
Debt / FCF = 11.11 (Net Debt 29.61b / FCF TTM 2.67b)
Total Stockholder Equity = -1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -14.66% (Net Income -4.62b / Total Assets 31.50b)
RoE = 433.5% (negative equity) (Net Income TTM -4.62b / Total Stockholder Equity -1.07b)
RoCE = -14.56% (EBIT -2.98b / Capital Employed (Equity -1.07b + L.T.Debt 21.55b))
RoIC = -12.67% (negative operating profit) (NOPAT -2.94b / Invested Capital 23.20b)
WACC = 4.05% (E(39.20b)/V(69.04b) * Re(6.52%) + D(29.84b)/V(69.04b) * Rd(0.83%) * (1-Tc(0.01)))
Discount Rate = 6.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 81.65 | Cagr: 0.35%
[DCF Debug] Terminal Value 79.32% ; FCFE base≈2.25b ; Y1≈2.42b ; Y5≈2.97b
Fair Price DCF = 119.2 (DCF Value 51.90b / Shares Outstanding 435.5m; 5y FCF grow 8.50% → 3.0% )
EPS Correlation: -43.52 | EPS CAGR: -6.09% | SUE: 0.03 | # QB: 0
Revenue Correlation: -72.63 | Revenue CAGR: -10.92% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.57 | Chg30d=-0.094 | Revisions Net=+2 | Analysts=8
EPS next Year (2026-12-31): EPS=3.44 | Chg30d=+0.212 | Revisions Net=+0 | Growth EPS=+41.9% | Growth Revenue=+1.8%
P/E Forward = 25.3165
P/S = 6.1055
P/B = 8.8551
P/EG = 1.3384
Beta = 0.961
Revenue TTM = 4.84b USD
EBIT TTM = -2.98b USD
EBITDA TTM = -2.03b USD
Long Term Debt = 21.55b USD (from longTermDebt, last quarter)
Short Term Debt = 3.31b USD (from shortTermDebt, last quarter)
Debt = 29.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.61b USD (from netDebt column, last quarter)
Enterprise Value = 68.81b USD (39.20b + Debt 29.84b - CCE 233.0m)
Interest Coverage Ratio = -3.17 (Ebit TTM -2.98b / Interest Expense TTM 942.0m)
FCF Yield = 3.87% (FCF TTM 2.67b / Enterprise Value 68.81b)
FCF Margin = 55.04% (FCF TTM 2.67b / Revenue TTM 4.84b)
Net Margin = -95.37% (Net Income TTM -4.62b / Revenue TTM 4.84b)
Gross Margin = 73.36% ((Revenue TTM 4.84b - Cost of Revenue TTM 1.29b) / Revenue TTM)
Gross Margin QoQ = 73.88% (prev 73.77%)
Tobins Q-Ratio = 2.18 (Enterprise Value 68.81b / Total Assets 31.50b)
Interest Expense / Debt = 0.83% (Interest Expense 247.0m / Debt 29.84b)
Taxrate = 1.42% (4.00m / 281.0m)
NOPAT = -2.94b (EBIT -2.98b * (1 - 1.42%)) [loss with tax shield]
Current Ratio = 0.26 (Total Current Assets 1.11b / Total Current Liabilities 4.30b)
Debt / Equity = -19.99 (negative equity) (Debt 29.84b / totalStockholderEquity, last quarter -1.49b)
Debt / EBITDA = -14.62 (negative EBITDA) (Net Debt 29.61b / EBITDA -2.03b)
Debt / FCF = 11.11 (Net Debt 29.61b / FCF TTM 2.67b)
Total Stockholder Equity = -1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -14.66% (Net Income -4.62b / Total Assets 31.50b)
RoE = 433.5% (negative equity) (Net Income TTM -4.62b / Total Stockholder Equity -1.07b)
RoCE = -14.56% (EBIT -2.98b / Capital Employed (Equity -1.07b + L.T.Debt 21.55b))
RoIC = -12.67% (negative operating profit) (NOPAT -2.94b / Invested Capital 23.20b)
WACC = 4.05% (E(39.20b)/V(69.04b) * Re(6.52%) + D(29.84b)/V(69.04b) * Rd(0.83%) * (1-Tc(0.01)))
Discount Rate = 6.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 81.65 | Cagr: 0.35%
[DCF Debug] Terminal Value 79.32% ; FCFE base≈2.25b ; Y1≈2.42b ; Y5≈2.97b
Fair Price DCF = 119.2 (DCF Value 51.90b / Shares Outstanding 435.5m; 5y FCF grow 8.50% → 3.0% )
EPS Correlation: -43.52 | EPS CAGR: -6.09% | SUE: 0.03 | # QB: 0
Revenue Correlation: -72.63 | Revenue CAGR: -10.92% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.57 | Chg30d=-0.094 | Revisions Net=+2 | Analysts=8
EPS next Year (2026-12-31): EPS=3.44 | Chg30d=+0.212 | Revisions Net=+0 | Growth EPS=+41.9% | Growth Revenue=+1.8%
Additional Sources for CCI Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle